Biotechnology
The Biotechnology industry has a total of 611 stocks, with a combined market cap of $1.09 trillion and total revenue of $104.99 billion.
Market Cap
1.09T
Revenue
104.99B
Profits
-42.96B
PE Ratio
n/a
Profit Margin
-40.92%
Dividend Yield
0.04%
610 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 107.58B | -0.65% | 2,256,258 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.12B | 0.73% | 1,568,529 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 57.37B | -0.49% | 1,726,873 | 3.21B |
| 4 | ARGX | argenx SE | 55.40B | -1.25% | 576,602 | 3.68B |
| 5 | INSM | Insmed Incorporated | 44.13B | 4.11% | 15,677,775 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 36.82B | -4.32% | 637,251 | 5.00B |
| 7 | BNTX | BioNTech SE | 23.21B | 0.99% | 1,457,294 | 3.70B |
| 8 | RPRX | Royalty Pharma plc | 22.95B | 2.13% | 8,168,855 | 2.35B |
| 9 | INCY | Incyte Corporation | 20.86B | 4.10% | 2,650,028 | 4.81B |
| 10 | GMAB | Genmab A/S | 19.05B | 1.22% | 1,655,041 | 3.85B |
| 11 | RVMD | Revolution Medicines, Inc. | 14.24B | 3.94% | 2,714,099 | - |
| 12 | ROIV | Roivant Sciences Ltd. | 14.12B | 0.40% | 6,375,971 | 20.33M |
| 13 | SMMT | Summit Therapeutics Inc. | 13.76B | 10.19% | 3,330,108 | - |
| 14 | BBIO | BridgeBio Pharma, Inc. | 13.68B | 4.23% | 4,527,681 | 353.78M |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.35B | 7.29% | 761,198 | 740.64M |
| 16 | ASND | Ascendis Pharma A/S | 12.77B | -0.69% | 526,174 | 758.59M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.72B | 3.19% | 3,042,460 | 966.96M |
| 18 | EXEL | Exelixis, Inc. | 11.37B | -0.61% | 3,975,796 | 2.29B |
| 19 | JAZZ | Jazz Pharmaceuticals plc | 10.99B | 2.24% | 2,032,179 | 4.16B |
| 20 | RNA | Avidity Biosciences, Inc. | 10.73B | 0.91% | 2,831,160 | 20.87M |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.66B | 1.48% | 17,315,319 | 3.09B |
| 22 | TECH | Bio-Techne Corporation | 9.89B | 3.19% | 2,908,536 | 1.22B |
| 23 | MRNA | Moderna, Inc. | 9.44B | 1.81% | 9,541,440 | 2.23B |
| 24 | ABVX | ABIVAX Société Anonyme | 9.35B | 5.53% | 1,790,400 | 7.07M |
| 25 | HALO | Halozyme Therapeutics, Inc. | 8.70B | 5.20% | 5,713,663 | 1.24B |
| 26 | CYTK | Cytokinetics, Incorporated | 8.22B | 2.70% | 1,819,702 | 87.21M |
| 27 | CORT | Corcept Therapeutics Incorporated | 8.17B | 0.54% | 453,889 | 741.17M |
| 28 | NUVL | Nuvalent, Inc. | 7.96B | 3.45% | 716,948 | - |
| 29 | AXSM | Axsome Therapeutics, Inc. | 7.62B | 1.18% | 540,329 | 561.26M |
| 30 | MRUS | Merus N.V. | 7.28B | 0.20% | 1,163,233 | 56.61M |
| 31 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.11B | 4.76% | 917,098 | 174.33M |
| 32 | CAI | Caris Life Sciences, Inc. | 7.10B | 4.40% | 1,828,033 | 649.06M |
| 33 | CDTX | Cidara Therapeutics, Inc. | 6.92B | 0.41% | 1,373,653 | 302.00K |
| 34 | PCVX | Vaxcyte, Inc. | 6.45B | 3.08% | 1,125,346 | - |
| 35 | PTCT | PTC Therapeutics, Inc. | 6.41B | 1.73% | 1,174,117 | 1.78B |
| 36 | KRYS | Krystal Biotech, Inc. | 6.23B | 1.35% | 276,939 | 373.16M |
| 37 | ARWR | Arrowhead Pharmaceuticals, Inc. | 6.12B | 9.42% | 4,005,289 | 572.98M |
| 38 | COGT | Cogent Biosciences, Inc. | 5.86B | 4.84% | 3,839,155 | - |
| 39 | PTGX | Protagonist Therapeutics, Inc. | 5.48B | 2.68% | 872,349 | 209.22M |
| 40 | LEGN | Legend Biotech Corporation | 5.01B | -3.62% | 6,277,308 | 909.05M |
| 41 | CRSP | CRISPR Therapeutics AG | 4.88B | 2.03% | 2,487,841 | 38.34M |
| 42 | PRAX | Praxis Precision Medicines, Inc. | 4.77B | 12.40% | 1,611,912 | 7.46M |
| 43 | BLTE | Belite Bio, Inc | 4.75B | 12.84% | 285,607 | - |
| 44 | KYMR | Kymera Therapeutics, Inc. | 4.72B | -0.68% | 1,022,706 | 43.74M |
| 45 | TGTX | TG Therapeutics, Inc. | 4.68B | 0.25% | 2,722,216 | 531.90M |
| 46 | CELC | Celcuity Inc. | 4.68B | 3.74% | 1,180,841 | - |
| 47 | APGE | Apogee Therapeutics, Inc. | 4.58B | 2.40% | 1,106,978 | - |
| 48 | AKRO | Akero Therapeutics, Inc. | 4.48B | 0.09% | 1,653,050 | - |
| 49 | NAMS | NewAmsterdam Pharma Company N.V. | 4.46B | 2.72% | 928,970 | 35.24M |
| 50 | ADMA | ADMA Biologics, Inc. | 4.36B | 6.64% | 5,153,758 | 488.56M |
| 51 | ACLX | Arcellx, Inc. | 4.33B | -16.89% | 4,619,923 | 35.90M |
| 52 | CNTA | Centessa Pharmaceuticals plc | 4.29B | 4.97% | 1,299,777 | 15.00M |
| 53 | SRRK | Scholar Rock Holding Corporation | 4.26B | 3.93% | 1,427,158 | - |
| 54 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.16B | 2.29% | 1,192,852 | 1.54M |
| 55 | IMVT | Immunovant, Inc. | 4.09B | 3.23% | 1,446,316 | - |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 4.04B | 1.44% | 1,824,225 | 1.05B |
| 57 | VKTX | Viking Therapeutics, Inc. | 3.92B | 1.14% | 2,590,541 | - |
| 58 | ARQT | Arcutis Biotherapeutics, Inc. | 3.77B | 4.31% | 3,800,022 | 317.93M |
| 59 | MIRM | Mirum Pharmaceuticals, Inc. | 3.71B | 1.73% | 285,678 | 471.79M |
| 60 | IRON | Disc Medicine, Inc. | 3.55B | 1.63% | 1,702,876 | - |
| 61 | CGON | CG Oncology, Inc. | 3.51B | 2.64% | 909,607 | 2.17M |
| 62 | TARS | Tarsus Pharmaceuticals, Inc. | 3.49B | 3.08% | 372,028 | 366.10M |
| 63 | MLYS | Mineralys Therapeutics, Inc. | 3.37B | 1.74% | 1,674,907 | - |
| 64 | XENE | Xenon Pharmaceuticals Inc. | 3.25B | 2.16% | 966,399 | 7.50M |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.25B | 2.53% | 74,418 | 664.23M |
| 66 | TVTX | Travere Therapeutics, Inc. | 3.20B | 3.17% | 1,381,561 | 435.83M |
| 67 | RARE | Ultragenyx Pharmaceutical Inc. | 3.16B | -2.41% | 1,878,437 | 630.60M |
| 68 | ADPT | Adaptive Biotechnologies Corporation | 3.12B | 9.94% | 4,340,254 | 252.75M |
| 69 | DYN | Dyne Therapeutics, Inc. | 3.10B | 2.31% | 2,180,615 | - |
| 70 | VRDN | Viridian Therapeutics, Inc. | 3.06B | 5.57% | 3,783,003 | 70.79M |
| 71 | FOLD | Amicus Therapeutics, Inc. | 3.05B | 3.45% | 16,199,022 | 598.70M |
| 72 | IDYA | IDEAYA Biosciences, Inc. | 3.04B | 1.97% | 672,830 | 214.83M |
| 73 | AAPG | Ascentage Pharma Group International | 2.93B | 4.54% | 3,565 | 54.52M |
| 74 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.89B | 0.99% | 1,157,310 | 578.20M |
| 75 | RCUS | Arcus Biosciences, Inc. | 2.87B | 5.12% | 2,229,687 | 240.00M |
| 76 | DNLI | Denali Therapeutics Inc. | 2.78B | 5.17% | 1,848,040 | - |
| 77 | LQDA | Liquidia Corporation | 2.60B | 2.61% | 1,874,800 | 69.22M |
| 78 | OCUL | Ocular Therapeutix, Inc. | 2.58B | -1.14% | 4,266,237 | 55.78M |
| 79 | APLS | Apellis Pharmaceuticals, Inc. | 2.55B | 2.65% | 4,118,823 | 1.02B |
| 80 | NUVB | Nuvation Bio Inc. | 2.54B | 6.01% | 9,024,381 | 26.75M |
| 81 | TERN | Terns Pharmaceuticals, Inc. | 2.53B | 6.53% | 3,441,775 | - |
| 82 | EWTX | Edgewise Therapeutics, Inc. | 2.49B | 3.57% | 1,012,381 | - |
| 83 | SLNO | Soleno Therapeutics, Inc. | 2.47B | 1.77% | 1,619,122 | 98.68M |
| 84 | BEAM | Beam Therapeutics Inc. | 2.33B | 6.35% | 4,096,334 | 55.70M |
| 85 | RXRX | Recursion Pharmaceuticals, Inc. | 2.26B | 3.84% | 17,695,263 | 43.69M |
| 86 | ZLAB | Zai Lab Limited | 2.20B | -0.45% | 2,031,612 | 441.63M |
| 87 | GPCR | Structure Therapeutics Inc. | 2.14B | 2.86% | 685,278 | - |
| 88 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | 2.74% | 2,379,201 | 265.81M |
| 89 | IBRX | ImmunityBio, Inc. | 2.12B | 3.37% | 9,433,689 | 82.56M |
| 90 | SYRE | Spyre Therapeutics, Inc. | 2.09B | 11.17% | 946,593 | - |
| 91 | ZBIO | Zenas BioPharma, Inc. | 2.05B | 6.84% | 647,715 | 15.00M |
| 92 | GLPG | Galapagos NV | 2.04B | 1.27% | 66,584 | 336.64M |
| 93 | HRMY | Harmony Biosciences Holdings, Inc. | 2.03B | 2.80% | 1,241,456 | 825.94M |
| 94 | SRPT | Sarepta Therapeutics, Inc. | 1.98B | 6.90% | 4,427,144 | 2.41B |
| 95 | SION | Sionna Therapeutics, Inc. | 1.97B | 1.19% | 415,227 | - |
| 96 | VCEL | Vericel Corporation | 1.97B | -1.77% | 1,086,196 | 258.72M |
| 97 | IMCR | Immunocore Holdings plc | 1.96B | -1.68% | 305,474 | 379.59M |
| 98 | MESO | Mesoblast Limited | 1.93B | 1.63% | 260,229 | 17.20M |
| 99 | JANX | Janux Therapeutics, Inc. | 1.90B | 9.48% | 1,302,789 | 10.00M |
| 100 | DNTH | Dianthus Therapeutics, Inc. | 1.87B | 5.38% | 1,082,727 | 3.08M |
| 101 | ZYME | Zymeworks Inc. | 1.87B | 4.04% | 2,634,916 | 134.48M |
| 102 | VERA | Vera Therapeutics, Inc. | 1.87B | 2.74% | 1,200,785 | - |
| 103 | MAZE | Maze Therapeutics, Inc. | 1.76B | 1.10% | 300,426 | 2.50M |
| 104 | CLDX | Celldex Therapeutics, Inc. | 1.75B | 1.54% | 722,936 | 2.60M |
| 105 | NRIX | Nurix Therapeutics, Inc. | 1.74B | 2.33% | 2,676,487 | 83.69M |
| 106 | STOK | Stoke Therapeutics, Inc. | 1.73B | 3.41% | 733,694 | 205.63M |
| 107 | QURE | uniQure N.V. | 1.73B | -0.11% | 2,375,678 | 15.75M |
| 108 | OLMA | Olema Pharmaceuticals, Inc. | 1.72B | 8.11% | 5,377,661 | - |
| 109 | SNDX | Syndax Pharmaceuticals, Inc. | 1.72B | 13.30% | 4,458,243 | 111.30M |
| 110 | IMNM | Immunome, Inc. | 1.71B | 0.65% | 1,049,539 | 9.68M |
| 111 | PHVS | Pharvaris N.V. | 1.65B | 2.17% | 516,057 | - |
| 112 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.63B | 1.02% | 3,183,538 | -665.00K |
| 113 | INVA | Innoviva, Inc. | 1.59B | 1.57% | 1,128,959 | 388.52M |
| 114 | MNKD | MannKind Corporation | 1.58B | 1.99% | 2,314,791 | 313.79M |
| 115 | AGIO | Agios Pharmaceuticals, Inc. | 1.54B | 4.95% | 4,258,526 | 44.79M |
| 116 | TRVI | Trevi Therapeutics, Inc. | 1.46B | 3.82% | 2,216,413 | - |
| 117 | ORKA | Oruka Therapeutics, Inc. | 1.45B | 1.98% | 1,069,931 | - |
| 118 | RLAY | Relay Therapeutics, Inc. | 1.42B | 20.68% | 4,058,784 | 8.36M |
| 119 | UPB | Upstream Bio, Inc. | 1.41B | 1.96% | 1,256,100 | 2.80M |
| 120 | MBX | MBX Biosciences, Inc. | 1.40B | 15.36% | 1,022,929 | - |
| 121 | TNGX | Tango Therapeutics, Inc. | 1.39B | 2.99% | 7,620,663 | 66.50M |
| 122 | PGEN | Precigen, Inc. | 1.35B | -1.55% | 6,546,073 | 6.31M |
| 123 | RAPP | Rapport Therapeutics, Inc. | 1.35B | 3.93% | 889,123 | - |
| 124 | ARDX | Ardelyx, Inc. | 1.34B | 1.48% | 2,352,725 | 398.23M |
| 125 | ELVN | Enliven Therapeutics, Inc. | 1.29B | 0.09% | 442,692 | - |
| 126 | IMTX | Immatics N.V. | 1.29B | 3.92% | 626,070 | 99.45M |
| 127 | BHVN | Biohaven Ltd. | 1.28B | -0.10% | 4,628,856 | - |
| 128 | SEPN | Septerna, Inc. | 1.28B | 11.54% | 546,382 | 22.05M |
| 129 | URGN | UroGen Pharma Ltd. | 1.26B | 4.10% | 1,480,980 | 96.52M |
| 130 | SVRA | Savara Inc. | 1.26B | 5.89% | 2,802,482 | - |
| 131 | WVE | Wave Life Sciences Ltd. | 1.25B | 5.82% | 2,926,595 | 109.23M |
| 132 | TSHA | Taysha Gene Therapies, Inc. | 1.21B | 5.49% | 5,937,975 | 6.31M |
| 133 | XNCR | Xencor, Inc. | 1.20B | 5.48% | 689,985 | 150.13M |
| 134 | NKTR | Nektar Therapeutics | 1.19B | 8.03% | 944,332 | 62.60M |
| 135 | EYPT | EyePoint Pharmaceuticals, Inc. | 1.19B | 5.21% | 930,841 | 42.34M |
| 136 | TYRA | Tyra Biosciences, Inc. | 1.19B | 5.40% | 460,604 | - |
| 137 | INBX | Inhibrx Biosciences, Inc. | 1.18B | -3.48% | 272,857 | 1.40M |
| 138 | XERS | Xeris Biopharma Holdings, Inc. | 1.17B | 3.07% | 2,347,974 | 266.14M |
| 139 | ANAB | AnaptysBio, Inc. | 1.16B | 5.91% | 750,118 | 169.47M |
| 140 | PVLA | Palvella Therapeutics, Inc. | 1.16B | 4.19% | 595,085 | - |
| 141 | KOD | Kodiak Sciences Inc. | 1.16B | 5.30% | 891,053 | - |
| 142 | MNMD | Mind Medicine (MindMed) Inc. | 1.16B | 10.02% | 2,134,081 | - |
| 143 | PHAR | Pharming Group N.V. | 1.16B | 5.29% | 16,811 | 362.27M |
| 144 | CVAC | CureVac N.V. | 1.15B | 1.59% | 1,295,517 | 83.00M |
| 145 | ORIC | ORIC Pharmaceuticals, Inc. | 1.15B | 1.46% | 1,382,820 | - |
| 146 | OCS | Oculis Holding AG | 1.12B | 0.05% | 102,924 | 992.00K |
| 147 | FTRE | Fortrea Holdings Inc. | 1.10B | 9.63% | 3,220,344 | 2.76B |
| 148 | NVAX | Novavax, Inc. | 1.08B | 2.47% | 4,084,837 | 1.06B |
| 149 | ABCL | AbCellera Biologics Inc. | 1.07B | 1.71% | 5,870,443 | 35.33M |
| 150 | NBTX | Nanobiotix S.A. | 1.05B | 5.11% | 63,841 | 11.93M |
| 151 | BCAX | Bicara Therapeutics Inc. | 1.03B | 4.66% | 1,936,769 | - |
| 152 | PHAT | Phathom Pharmaceuticals, Inc. | 1.03B | -1.20% | 1,403,346 | 147.19M |
| 153 | GLUE | Monte Rosa Therapeutics, Inc. | 1.03B | 10.83% | 1,588,285 | 181.54M |
| 154 | KURA | Kura Oncology, Inc. | 1.02B | 5.01% | 1,687,280 | 104.03M |
| 155 | MDXG | MiMedx Group, Inc. | 1.00B | 0.30% | 855,632 | 393.44M |
| 156 | LENZ | LENZ Therapeutics, Inc. | 999.40M | 8.05% | 1,005,102 | 17.50M |
| 157 | IOVA | Iovance Biotherapeutics, Inc. | 992.42M | 11.61% | 15,992,808 | 250.43M |
| 158 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 983.06M | -0.81% | 98,656 | - |
| 159 | NTLA | Intellia Therapeutics, Inc. | 967.18M | 1.71% | 3,962,626 | 57.53M |
| 160 | SANA | Sana Biotechnology, Inc. | 942.94M | 7.60% | 3,612,965 | - |
| 161 | MRVI | Maravai LifeSciences Holdings, Inc. | 941.00M | -1.87% | 1,196,730 | 192.44M |
| 162 | MLTX | MoonLake Immunotherapeutics | 938.56M | 3.79% | 1,919,416 | - |
| 163 | TBPH | Theravance Biopharma, Inc. | 937.44M | 0.11% | 732,925 | 80.33M |
| 164 | DAWN | Day One Biopharmaceuticals, Inc. | 911.76M | 4.23% | 3,833,318 | 133.67M |
| 165 | RZLT | Rezolute, Inc. | 905.95M | -0.61% | 1,413,601 | - |
| 166 | GHRS | GH Research PLC | 904.39M | 3.99% | 337,291 | - |
| 167 | RIGL | Rigel Pharmaceuticals, Inc. | 903.94M | 7.75% | 757,594 | 282.08M |
| 168 | AVBP | ArriVent BioPharma, Inc. | 887.96M | 5.70% | 307,744 | - |
| 169 | CMPX | Compass Therapeutics, Inc. | 880.42M | 1.64% | 2,328,088 | 850.00K |
| 170 | VIR | Vir Biotechnology, Inc. | 851.45M | 7.75% | 2,712,283 | 16.86M |
| 171 | ATAI | Atai Beckley N.V. | 823.06M | 1.05% | 6,142,766 | 3.02M |
| 172 | ABUS | Arbutus Biopharma Corporation | 821.22M | -0.93% | 1,591,211 | 14.61M |
| 173 | ERAS | Erasca, Inc. | 819.93M | -1.03% | 1,895,897 | - |
| 174 | RAPT | RAPT Therapeutics, Inc. | 806.94M | 7.53% | 368,765 | - |
| 175 | SPRY | ARS Pharmaceuticals, Inc. | 793.75M | 5.80% | 2,648,697 | 142.77M |
| 176 | CRMD | CorMedix Inc. | 773.71M | 1.45% | 3,108,726 | 214.30M |
| 177 | CGEM | Cullinan Therapeutics, Inc. | 763.86M | 36.54% | 5,129,250 | - |
| 178 | ALMS | Alumis Inc. | 762.07M | - | 1,373,320 | 22.12M |
| 179 | VSTM | Verastem, Inc. | 759.47M | -1.60% | 7,056,471 | 13.38M |
| 180 | ARVN | Arvinas, Inc. | 755.92M | 2.17% | 1,486,898 | 312.30M |
| 181 | VALN | Valneva SE | 751.59M | 3.02% | 8,687 | 211.09M |
| 182 | GERN | Geron Corporation | 740.49M | 3.57% | 7,014,110 | 183.40M |
| 183 | REPL | Replimune Group, Inc. | 736.58M | 2.07% | 2,378,601 | - |
| 184 | GOSS | Gossamer Bio, Inc. | 736.03M | 3.92% | 2,726,870 | 44.05M |
| 185 | LXEO | Lexeo Therapeutics, Inc. | 729.14M | 10.26% | 1,404,758 | - |
| 186 | GYRE | Gyre Therapeutics, Inc. | 715.31M | 4.24% | 62,052 | 107.27M |
| 187 | VTYX | Ventyx Biosciences, Inc. | 710.02M | 5.51% | 1,773,323 | - |
| 188 | ATXS | Astria Therapeutics, Inc. | 705.00M | -1.28% | 1,272,939 | 706.00K |
| 189 | OMER | Omeros Corporation | 691.99M | 10.03% | 2,516,071 | - |
| 190 | KALV | KalVista Pharmaceuticals, Inc. | 675.30M | 1.98% | 1,241,060 | 1.43M |
| 191 | CTMX | CytomX Therapeutics, Inc. | 672.66M | 2.32% | 2,657,659 | 113.63M |
| 192 | PRME | Prime Medicine, Inc. | 670.97M | 4.41% | 3,549,118 | 5.98M |
| 193 | ANNX | Annexon, Inc. | 652.73M | 5.62% | 3,835,322 | - |
| 194 | PROK | ProKidney Corp. | 643.79M | -2.28% | 918,759 | 744.00K |
| 195 | CRVS | Corvus Pharmaceuticals, Inc. | 640.77M | 0.12% | 959,392 | - |
| 196 | FULC | Fulcrum Therapeutics, Inc. | 635.35M | 3.99% | 701,997 | 80.00M |
| 197 | FDMT | 4D Molecular Therapeutics, Inc. | 622.20M | 0.46% | 484,759 | 120.00K |
| 198 | YDES | YD Bio Limited | 620.92M | 4.50% | 69,268 | 510.36K |
| 199 | RGNX | REGENXBIO Inc. | 619.12M | 3.64% | 1,060,130 | 161.32M |
| 200 | MNPR | Monopar Therapeutics Inc. | 618.61M | 1.10% | 171,030 | - |
| 201 | MGTX | MeiraGTx Holdings plc | 609.32M | 1.47% | 470,690 | 27.42M |
| 202 | ASMB | Assembly Biosciences, Inc. | 599.94M | -1.48% | 79,466 | 37.19M |
| 203 | EVMN | Evommune, Inc. | 582.90M | 3.58% | 37,030 | 3.00M |
| 204 | MPLT | MapLight Therapeutics, Inc. | 567.34M | -7.08% | 275,995 | - |
| 205 | IVA | Inventiva S.A. | 561.22M | -6.05% | 73,056 | 19.93M |
| 206 | PRTA | Prothena Corporation plc | 559.83M | -0.76% | 776,117 | 11.79M |
| 207 | IVVD | Invivyd, Inc. | 559.49M | -4.00% | 3,798,081 | 50.04M |
| 208 | JBIO | Jade Biosciences, Inc. | 558.95M | 1.25% | 269,615 | - |
| 209 | NAGE | Niagen Bioscience, Inc. | 549.41M | -0.29% | 928,930 | 124.71M |
| 210 | ADCT | ADC Therapeutics SA | 541.34M | 8.71% | 971,593 | 75.21M |
| 211 | ALT | Altimmune, Inc. | 532.15M | 6.03% | 4,681,502 | 20.00K |
| 212 | KROS | Keros Therapeutics, Inc. | 518.23M | -2.19% | 1,565,773 | 246.72M |
| 213 | LXRX | Lexicon Pharmaceuticals, Inc. | 516.03M | 5.97% | 999,052 | 70.86M |
| 214 | DSGN | Design Therapeutics, Inc. | 492.17M | 3.47% | 217,518 | - |
| 215 | DNA | Ginkgo Bioworks Holdings, Inc. | 489.36M | 5.39% | 1,372,386 | 180.61M |
| 216 | ZVRA | Zevra Therapeutics, Inc. | 486.97M | 0.58% | 1,199,274 | 84.39M |
| 217 | IMRX | Immuneering Corporation | 483.63M | 2.60% | 1,205,350 | - |
| 218 | LYEL | Lyell Immunopharma, Inc. | 482.08M | 18.77% | 92,801 | 41.00K |
| 219 | ENGN | enGene Holdings Inc. | 478.52M | 6.47% | 470,312 | - |
| 220 | DRUG | Bright Minds Biosciences Inc. | 471.58M | 3.21% | 89,876 | - |
| 221 | DBVT | DBV Technologies S.A. | 470.18M | -2.69% | 131,128 | 5.50M |
| 222 | BCYC | Bicycle Therapeutics plc | 467.54M | 6.65% | 379,901 | 28.34M |
| 223 | NBP | NovaBridge Biosciences | 462.22M | -5.20% | 482,338 | - |
| 224 | ABSI | Absci Corporation | 445.10M | 1.02% | 3,001,025 | 2.82M |
| 225 | BNTC | Benitec Biopharma Inc. | 442.58M | -1.73% | 94,619 | - |
| 226 | LCTX | Lineage Cell Therapeutics, Inc. | 424.07M | 0.57% | 3,236,833 | 10.82M |
| 227 | DMAC | DiaMedica Therapeutics Inc. | 416.62M | 4.85% | 353,830 | - |
| 228 | ANRO | Alto Neuroscience, Inc. | 413.18M | 0.38% | 218,656 | - |
| 229 | LBRX | LB Pharmaceuticals Inc | 408.33M | 5.28% | 119,646 | - |
| 230 | PEPG | PepGen Inc. | 398.05M | 4.14% | 1,306,378 | - |
| 231 | ENTA | Enanta Pharmaceuticals, Inc. | 393.97M | 7.23% | 457,375 | 65.32M |
| 232 | XOMA | XOMA Royalty Corporation | 393.78M | -0.06% | 78,449 | 47.11M |
| 233 | PRTC | PureTech Health plc | 390.06M | -1.00% | 796 | 6.39M |
| 234 | SLDB | Solid Biosciences Inc. | 382.54M | 4.47% | 839,824 | - |
| 235 | CLLS | Cellectis S.A. | 379.21M | 14.07% | 312,658 | 82.55M |
| 236 | OCGN | Ocugen, Inc. | 371.66M | 2.59% | 2,533,811 | 5.37M |
| 237 | VTVT | vTv Therapeutics Inc. | 370.53M | 1.01% | 13,899 | 17.00K |
| 238 | TECX | Tectonic Therapeutic, Inc. | 367.96M | 2.50% | 383,037 | - |
| 239 | TENX | Tenax Therapeutics, Inc. | 365.13M | 10.43% | 172,507 | - |
| 240 | NMRA | Neumora Therapeutics, Inc. | 360.91M | -7.30% | 1,634,503 | - |
| 241 | GALT | Galectin Therapeutics Inc. | 355.25M | 2.99% | 211,663 | - |
| 242 | TRDA | Entrada Therapeutics, Inc. | 354.67M | -2.18% | 246,925 | 61.52M |
| 243 | AURA | Aura Biosciences, Inc. | 349.27M | 1.10% | 225,250 | - |
| 244 | FBRX | Forte Biosciences, Inc. | 339.87M | 3.47% | 134,009 | - |
| 245 | PALI | Palisade Bio, Inc. | 339.73M | 7.04% | 3,329,450 | - |
| 246 | XFOR | X4 Pharmaceuticals, Inc. | 332.26M | 1.33% | 496,246 | 33.98M |
| 247 | AUTL | Autolus Therapeutics plc | 330.02M | 0.81% | 1,420,566 | 51.13M |
| 248 | KYTX | Kyverna Therapeutics, Inc. | 328.03M | 5.64% | 346,615 | - |
| 249 | RCKT | Rocket Pharmaceuticals, Inc. | 327.91M | 3.41% | 1,295,563 | - |
| 250 | AVTX | Avalo Therapeutics, Inc. | 326.41M | 0.95% | 325,979 | 192.00K |
| 251 | PYXS | Pyxis Oncology, Inc. | 320.66M | 7.29% | 697,345 | 2.82M |
| 252 | EPRX | Eupraxia Pharmaceuticals Inc. | 318.97M | -0.16% | 754,712 | - |
| 253 | NGNE | Neurogene Inc. | 316.61M | 1.89% | 105,344 | 925.00K |
| 254 | RLMD | Relmada Therapeutics, Inc. | 315.33M | 0.70% | 718,057 | - |
| 255 | ALDX | Aldeyra Therapeutics, Inc. | 314.65M | 5.44% | 827,363 | - |
| 256 | LRMR | Larimar Therapeutics, Inc. | 313.26M | 2.81% | 502,023 | - |
| 257 | DRTS | Alpha Tau Medical Ltd. | 310.41M | -4.45% | 43,260 | - |
| 258 | ACIU | AC Immune SA | 304.74M | 2.67% | 146,156 | 5.48M |
| 259 | ALLO | Allogene Therapeutics, Inc. | 303.39M | 9.76% | 3,836,642 | 22.00K |
| 260 | CTNM | Contineum Therapeutics, Inc. | 302.33M | -5.39% | 180,040 | - |
| 261 | ACRS | Aclaris Therapeutics, Inc. | 297.95M | 9.56% | 2,065,995 | 15.74M |
| 262 | SLN | Silence Therapeutics plc | 297.57M | -0.16% | 490,325 | 25.83M |
| 263 | CYBN | Cybin Inc. | 293.93M | 5.37% | 365,322 | - |
| 264 | VNDA | Vanda Pharmaceuticals Inc. | 288.98M | 1.87% | 584,624 | 212.07M |
| 265 | MREO | Mereo BioPharma Group plc | 284.85M | -0.56% | 1,446,450 | 500.00K |
| 266 | TARA | Protara Therapeutics, Inc. | 284.39M | 1.52% | 761,920 | - |
| 267 | CBIO | Crescent Biopharma, Inc. | 274.67M | 7.58% | 43,674 | - |
| 268 | OBIO | Orchestra BioMed Holdings, Inc. | 273.29M | 6.84% | 383,822 | 2.82M |
| 269 | AVXL | Anavex Life Sciences Corp. | 264.55M | -5.52% | 3,999,803 | - |
| 270 | FENC | Fennec Pharmaceuticals Inc. | 263.66M | -2.03% | 92,599 | 38.79M |
| 271 | NAUT | Nautilus Biotechnology, Inc. | 261.45M | -7.59% | 451,455 | - |
| 272 | FHTX | Foghorn Therapeutics Inc. | 257.87M | -1.30% | 162,892 | 24.52M |
| 273 | PBYI | Puma Biotechnology, Inc. | 250.95M | 1.84% | 465,057 | 212.00M |
| 274 | ARMP | Armata Pharmaceuticals, Inc. | 249.22M | -2.42% | 49,919 | 5.05M |
| 275 | OABI | OmniAb, Inc. | 249.04M | -2.26% | 630,253 | 21.09M |
| 276 | ABEO | Abeona Therapeutics Inc. | 248.74M | 2.46% | 1,309,703 | 400.00K |
| 277 | CADL | Candel Therapeutics, Inc. | 248.69M | -0.44% | 616,314 | - |
| 278 | IMMP | Immutep Limited | 247.14M | 2.33% | 55,949 | 3.31M |
| 279 | EDIT | Editas Medicine, Inc. | 244.05M | 3.31% | 1,309,571 | 46.38M |
| 280 | ZURA | Zura Bio Limited | 243.19M | 3.03% | 252,954 | - |
| 281 | MIST | Milestone Pharmaceuticals Inc. | 240.75M | -1.25% | 3,686,172 | - |
| 282 | HUMA | Humacyte, Inc. | 239.71M | 4.92% | 5,401,648 | 1.57M |
| 283 | CCCC | C4 Therapeutics, Inc. | 238.41M | 0.82% | 892,108 | 30.11M |
| 284 | AVIR | Atea Pharmaceuticals, Inc. | 233.21M | 0.51% | 245,696 | - |
| 285 | MDWD | MediWound Ltd. | 232.32M | 6.21% | 113,014 | 20.93M |
| 286 | PRQR | ProQR Therapeutics N.V. | 231.76M | 6.80% | 289,581 | 18.86M |
| 287 | VYGR | Voyager Therapeutics, Inc. | 227.96M | -1.91% | 410,717 | 31.32M |
| 288 | CABA | Cabaletta Bio, Inc. | 221.41M | 10.58% | 2,218,333 | - |
| 289 | SLS | SELLAS Life Sciences Group, Inc. | 220.79M | 1.31% | 2,912,586 | - |
| 290 | ETHZ | ETHZilla Corporation | 220.19M | -1.15% | 1,048,664 | 4.11M |
| 291 | BDTX | Black Diamond Therapeutics, Inc. | 219.35M | 1.32% | 1,506,244 | 70.00M |
| 292 | SGMT | Sagimet Biosciences Inc. | 216.92M | - | 454,848 | - |
| 293 | CAPR | Capricor Therapeutics, Inc. | 212.13M | -19.30% | 6,888,699 | 11.13M |
| 294 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 211.97M | -4.75% | 300,913 | - |
| 295 | ACHV | Achieve Life Sciences, Inc. | 211.34M | 0.25% | 256,631 | - |
| 296 | HRTX | Heron Therapeutics, Inc. | 207.20M | 6.60% | 1,933,741 | 155.10M |
| 297 | AARD | Aardvark Therapeutics, Inc. | 206.85M | 1.39% | 138,903 | - |
| 298 | TLSA | Tiziana Life Sciences Ltd | 205.57M | -0.57% | 123,479 | - |
| 299 | TNYA | Tenaya Therapeutics, Inc. | 203.14M | -0.81% | 1,628,657 | - |
| 300 | RANI | Rani Therapeutics Holdings, Inc. | 201.71M | 1.84% | 3,406,267 | 1.20M |
| 301 | GUTS | Fractyl Health, Inc. | 200.08M | 4.29% | 3,199,157 | 3.00K |
| 302 | RNAC | Cartesian Therapeutics, Inc. | 193.21M | 2.62% | 150,387 | 1.09M |
| 303 | GNLX | Genelux Corporation | 191.85M | 2.82% | 126,338 | 8.00K |
| 304 | SABS | SAB Biotherapeutics, Inc. | 191.38M | 1.77% | 165,109 | 114.70K |
| 305 | VTGN | Vistagen Therapeutics, Inc. | 186.42M | 2.83% | 1,568,177 | 721.00K |
| 306 | ARCT | Arcturus Therapeutics Holdings Inc. | 179.85M | 1.12% | 778,237 | 97.60M |
| 307 | CRBU | Caribou Biosciences, Inc. | 174.79M | 6.86% | 1,004,442 | 9.30M |
| 308 | IPHA | Innate Pharma S.A. | 174.61M | -0.55% | 16,542 | 14.84M |
| 309 | VOR | Vor Biopharma Inc. | 170.63M | 12.21% | 918,052 | - |
| 310 | TNXP | Tonix Pharmaceuticals Holding Corp. | 168.23M | -11.27% | 1,233,806 | 10.30M |
| 311 | CNTB | Connect Biopharma Holdings Limited | 162.68M | -4.28% | 2,437,472 | 762.00K |
| 312 | CAMP | Camp4 Therapeutics Corporation | 156.11M | 14.83% | 146,661 | 3.80M |
| 313 | CHRS | Coherus Oncology, Inc. | 154.71M | 10.34% | 1,504,270 | 277.73M |
| 314 | MCRB | Seres Therapeutics, Inc. | 153.52M | -4.18% | 181,086 | 351.00K |
| 315 | NVCT | Nuvectis Pharma, Inc. | 153.43M | -1.97% | 102,578 | - |
| 316 | ELTX | Elicio Therapeutics, Inc. | 150.64M | 2.01% | 94,220 | - |
| 317 | CGEN | Compugen Ltd. | 148.72M | 3.92% | 353,631 | 6.90M |
| 318 | MOLN | Molecular Partners AG | 146.44M | -0.99% | 976 | 856.30K |
| 319 | AGEN | Agenus Inc. | 145.90M | 1.66% | 487,900 | 106.83M |
| 320 | ACTU | Actuate Therapeutics, Inc. | 145.50M | -0.08% | 39,604 | - |
| 321 | IMMX | Immix Biopharma, Inc. | 145.06M | -0.23% | 428,086 | - |
| 322 | CDXS | Codexis, Inc. | 143.62M | 3.25% | 930,688 | 52.93M |
| 323 | ANIX | Anixa Biosciences, Inc. | 143.19M | 0.23% | 105,327 | - |
| 324 | NTHI | NeOnc Technologies Holdings, Inc. | 142.55M | 24.91% | 88,158 | 59.99K |
| 325 | PLX | Protalix BioTherapeutics, Inc. | 140.74M | - | 367,731 | 61.84M |
| 326 | SGMO | Sangamo Therapeutics, Inc. | 140.18M | -1.61% | 9,511,755 | 32.88M |
| 327 | CRDF | Cardiff Oncology, Inc. | 140.11M | 2.46% | 534,783 | 501.00K |
| 328 | SAVA | Cassava Sciences, Inc. | 140.09M | 1.05% | 1,396,047 | - |
| 329 | ALEC | Alector, Inc. | 139.71M | 3.23% | 1,347,870 | 69.05M |
| 330 | QNCX | Quince Therapeutics, Inc. | 139.20M | 16.82% | 1,570,310 | - |
| 331 | IRD | Opus Genetics, Inc. | 137.93M | 4.71% | 247,152 | 14.63M |
| 332 | MRSN | Mersana Therapeutics, Inc. | 136.92M | 0.33% | 107,612 | 33.18M |
| 333 | CGTX | Cognition Therapeutics, Inc. | 135.06M | 10.07% | 867,213 | - |
| 334 | SPRO | Spero Therapeutics, Inc. | 134.09M | 3.03% | 627,019 | 40.55M |
| 335 | ACOG | Alpha Cognition Inc. | 130.89M | 4.70% | 22,723 | 7.43M |
| 336 | STTK | Shattuck Labs, Inc. | 130.36M | 1.48% | 180,980 | 1.00M |
| 337 | EXOZ | eXoZymes, Inc. | 129.92M | -3.19% | 1,269 | -700.00 |
| 338 | NKTX | Nkarta, Inc. | 127.14M | -0.56% | 535,875 | - |
| 339 | COYA | Coya Therapeutics, Inc. | 126.30M | 0.94% | 176,844 | 3.99M |
| 340 | FATE | Fate Therapeutics, Inc. | 124.58M | 4.85% | 915,848 | 7.14M |
| 341 | INO | Inovio Pharmaceuticals, Inc. | 124.35M | 2.84% | 932,214 | 182.34K |
| 342 | DTIL | Precision BioSciences, Inc. | 122.77M | 2.00% | 219,178 | 698.00K |
| 343 | CNTX | Context Therapeutics Inc. | 122.57M | 5.50% | 354,404 | - |
| 344 | ELDN | Eledon Pharmaceuticals, Inc. | 120.99M | 11.81% | 2,321,444 | - |
| 345 | KLRS | Kalaris Therapeutics, Inc. | 120.63M | -7.99% | 107,608 | - |
| 346 | CLYM | Climb Bio, Inc. | 120.00M | 3.82% | 296,147 | - |
| 347 | UNCY | Unicycive Therapeutics, Inc. | 118.63M | 2.22% | 322,356 | - |
| 348 | IKT | Inhibikase Therapeutics, Inc. | 116.52M | 4.03% | 733,463 | 1.00 |
| 349 | SLGL | Sol-Gel Technologies Ltd. | 116.33M | 13.94% | 17,872 | 18.97M |
| 350 | PRLD | Prelude Therapeutics Incorporated | 115.36M | -16.17% | 577,728 | 10.50M |
| 351 | NBY | NovaBay Pharmaceuticals, Inc. | 114.67M | 5.59% | 121,168 | 10.30M |
| 352 | SPRB | Spruce Biosciences, Inc. | 114.53M | 1.90% | 121,752 | 697.00K |
| 353 | SRZN | Surrozen, Inc. | 112.29M | -0.76% | 48,900 | 3.60M |
| 354 | ONCY | Oncolytics Biotech Inc. | 109.33M | 3.00% | 309,398 | - |
| 355 | SEER | Seer, Inc. | 108.79M | -1.02% | 145,894 | 16.38M |
| 356 | GLSI | Greenwich LifeSciences, Inc. | 108.76M | -3.68% | 83,631 | - |
| 357 | ENTX | Entera Bio Ltd. | 108.45M | -6.13% | 106,077 | 124.00K |
| 358 | ANVS | Annovis Bio, Inc. | 108.40M | 7.92% | 3,310,665 | - |
| 359 | OVID | Ovid Therapeutics Inc. | 106.11M | 6.43% | 3,028,652 | 6.61M |
| 360 | WHWK | Whitehawk Therapeutics, Inc. | 104.15M | 4.74% | 179,853 | 14.38M |
| 361 | ORMP | Oramed Pharmaceuticals Inc. | 103.09M | 0.39% | 233,819 | 2.00M |
| 362 | TTRX | Turn Therapeutics Inc. | 103.06M | 7.03% | 53,647 | - |
| 363 | ABOS | Acumen Pharmaceuticals, Inc. | 102.97M | 8.28% | 149,722 | - |
| 364 | GANX | Gain Therapeutics, Inc. | 102.16M | 6.39% | 643,551 | - |
| 365 | ATRA | Atara Biotherapeutics, Inc. | 101.16M | 2.56% | 73,966 | 151.93M |
| 366 | ZNTL | Zentalis Pharmaceuticals, Inc. | 100.43M | 3.73% | 581,926 | 26.87M |
| 367 | ACET | Adicet Bio, Inc. | 98.99M | 1.64% | 1,009,786 | - |
| 368 | ANEB | Anebulo Pharmaceuticals, Inc. | 97.22M | 0.48% | 5,718 | - |
| 369 | ATOS | Atossa Therapeutics, Inc. | 97.09M | -3.67% | 792,777 | - |
| 370 | HURA | TuHURA Biosciences, Inc. | 96.88M | 8.62% | 226,590 | - |
| 371 | PLRX | Pliant Therapeutics, Inc. | 96.48M | 1.29% | 384,390 | - |
| 372 | VANI | Vivani Medical, Inc. | 96.30M | - | 144,787 | - |
| 373 | KPTI | Karyopharm Therapeutics Inc. | 94.80M | -5.76% | 103,125 | 142.53M |
| 374 | COEP | Coeptis Therapeutics Holdings, Inc. | 94.25M | 4.52% | 67,888 | 501.00K |
| 375 | RPTX | Repare Therapeutics Inc. | 91.13M | 0.47% | 497,266 | 11.87M |
| 376 | ADVM | Adverum Biotechnologies, Inc. | 90.96M | -0.48% | 426,786 | 1.00M |
| 377 | CSBR | Champions Oncology, Inc. | 90.18M | -3.40% | 9,876 | 56.88M |
| 378 | MGNX | MacroGenics, Inc. | 89.83M | 1.43% | 880,694 | 127.63M |
| 379 | ADAG | Adagene Inc. | 89.55M | 5.56% | 81,179 | 103.20K |
| 380 | THAR | Tharimmune, Inc. | 89.01M | 3.67% | 183,149 | - |
| 381 | VXRT | Vaxart, Inc. | 86.60M | -0.85% | - | 148.20M |
| 382 | CRVO | CervoMed Inc. | 85.77M | 4.39% | 54,977 | 6.16M |
| 383 | PTHS | Pelthos Therapeutics Inc. | 84.29M | 8.39% | 17,550 | 7.41M |
| 384 | TVGN | Tevogen Bio Holdings Inc. | 84.24M | -5.97% | 276,006 | - |
| 385 | IMUX | Immunic, Inc. | 83.00M | 0.52% | 1,104,087 | - |
| 386 | ALXO | ALX Oncology Holdings Inc. | 81.87M | 5.59% | 166,915 | - |
| 387 | IFRX | InflaRx N.V. | 81.30M | 1.69% | 450,020 | 73.73K |
| 388 | ARTV | Artiva Biotherapeutics, Inc. | 81.24M | 5.75% | 98,497 | 251.00K |
| 389 | HYFT | MindWalk Holdings Corp. | 81.23M | 5.39% | 101,218 | 18.21M |
| 390 | TIL | Instil Bio, Inc. | 80.23M | -9.97% | 116,950 | - |
| 391 | OTLK | Outlook Therapeutics, Inc. | 79.96M | -4.26% | 2,710,645 | 1.51M |
| 392 | FBIO | Fortress Biotech, Inc. | 79.61M | -0.97% | 307,091 | 62.30M |
| 393 | PSTV | Plus Therapeutics, Inc. | 79.05M | 7.98% | 8,518,751 | 5.26M |
| 394 | BYSI | BeyondSpring Inc. | 78.95M | 0.26% | 30,756 | 1.88M |
| 395 | OKYO | OKYO Pharma Limited | 77.48M | -2.83% | 86,911 | - |
| 396 | ATYR | aTyr Pharma, Inc. | 76.19M | 17.02% | 4,014,639 | 190.00K |
| 397 | STRO | Sutro Biopharma, Inc. | 74.49M | 3.76% | 722,821 | 105.65M |
| 398 | ACRV | Acrivon Therapeutics, Inc. | 74.47M | 2.61% | 270,253 | - |
| 399 | IMA | ImageneBio, Inc. | 73.60M | -2.81% | 71,127 | 800.00K |
| 400 | PMVP | PMV Pharmaceuticals, Inc. | 71.84M | 2.27% | 224,848 | - |
| 401 | BMEA | Biomea Fusion, Inc. | 71.41M | 2.85% | 1,100,427 | - |
| 402 | MNOV | MediciNova, Inc. | 69.65M | -0.70% | 442,585 | 257.92K |
| 403 | XBIT | XBiotech Inc. | 69.51M | 0.44% | 27,566 | - |
| 404 | CBUS | Cibus, Inc. | 68.94M | 0.79% | 197,252 | 3.79M |
| 405 | ESLA | Estrella Immunopharma, Inc. | 68.36M | 19.08% | 266,689 | - |
| 406 | LITS | Lite Strategy, Inc. | 67.32M | 7.65% | 626,788 | - |
| 407 | ATHE | Alterity Therapeutics Limited | 63.21M | 1.14% | 4,004 | 3.57M |
| 408 | NRXP | NRx Pharmaceuticals, Inc. | 62.94M | 5.16% | 262,925 | 242.00K |
| 409 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 60.80M | 3.14% | 2,725,878 | - |
| 410 | OSTX | OS Therapies Incorporated | 60.57M | 0.58% | 129,128 | - |
| 411 | CALC | CalciMedica, Inc. | 60.38M | 27.36% | 1,257,492 | - |
| 412 | PYPD | PolyPid Ltd. | 60.05M | 0.28% | 20,286 | - |
| 413 | MGX | Metagenomi, Inc. | 59.70M | 5.30% | 234,937 | 30.91M |
| 414 | ABVC | ABVC BioPharma, Inc. | 59.63M | -5.95% | 80,280 | 797.92K |
| 415 | ALGS | Aligos Therapeutics, Inc. | 58.55M | 3.31% | 92,429 | 2.65M |
| 416 | EQ | Equillium, Inc. | 57.64M | -1.40% | 676,865 | 4.39M |
| 417 | IOBT | IO Biotech, Inc. | 56.77M | -0.75% | 403,965 | - |
| 418 | NTRB | Nutriband Inc. | 56.23M | -2.09% | 27,298 | 2.58M |
| 419 | TCRX | TScan Therapeutics, Inc. | 56.19M | 2.85% | 727,309 | 8.42M |
| 420 | KRRO | Korro Bio, Inc. | 55.56M | -6.05% | 684,362 | 7.37M |
| 421 | SNTI | Senti Biosciences, Inc. | 54.95M | 7.73% | 198,622 | - |
| 422 | CELU | Celularity Inc. | 54.54M | 10.01% | 50,839 | 40.58M |
| 423 | CVM | CEL-SCI Corporation | 52.20M | 4.31% | 29,340 | - |
| 424 | ANL | Adlai Nortye Ltd. | 52.03M | 4.44% | 18,083 | 1.94M |
| 425 | INKT | MiNK Therapeutics, Inc. | 51.73M | 4.36% | 9,018 | - |
| 426 | BCAB | BioAtla, Inc. | 50.39M | -1.39% | 3,985,843 | 11.00M |
| 427 | JSPR | Jasper Therapeutics, Inc. | 48.13M | 1.18% | 616,973 | - |
| 428 | NXTC | NextCure, Inc. | 47.81M | 34.25% | 260,355 | - |
| 429 | HOWL | Werewolf Therapeutics, Inc. | 47.41M | 11.85% | 729,826 | 1.14M |
| 430 | CUE | Cue Biopharma, Inc. | 46.47M | -0.81% | 94,818 | 7.10M |
| 431 | KZR | Kezar Life Sciences, Inc. | 45.48M | -0.16% | 17,553 | - |
| 432 | IPSC | Century Therapeutics, Inc. | 45.40M | 6.12% | 1,362,448 | 113.34M |
| 433 | IBO | Impact BioMedical Inc. | 44.99M | -5.49% | 90,745 | 25.00K |
| 434 | VRCA | Verrica Pharmaceuticals Inc. | 44.79M | 12.11% | 581,848 | 30.83M |
| 435 | EVAX | Evaxion A/S | 44.42M | 3.28% | 54,439 | 7.65M |
| 436 | GRCE | Grace Therapeutics, Inc. | 43.94M | -2.51% | 60,341 | - |
| 437 | TELO | Telomir Pharmaceuticals, Inc. | 43.66M | -0.78% | 467,403 | - |
| 438 | ATNM | Actinium Pharmaceuticals, Inc. | 42.74M | 3.01% | 100,842 | 90.00K |
| 439 | ICCC | ImmuCell Corporation | 42.70M | 0.85% | 10,076 | 27.77M |
| 440 | BTAI | BioXcel Therapeutics, Inc. | 42.65M | 2.09% | 1,333,003 | 752.00K |
| 441 | GNTA | Genenta Science S.p.A. | 41.71M | 5.95% | 278,579 | - |
| 442 | SKYE | Skye Bioscience, Inc. | 41.67M | 11.59% | 241,754 | - |
| 443 | PDSB | PDS Biotechnology Corporation | 41.43M | 0.23% | 274,871 | - |
| 444 | JUNS | Jupiter Neurosciences, Inc. | 40.28M | -0.85% | 52,213 | - |
| 445 | SER | Serina Therapeutics, Inc. | 39.99M | -6.02% | 11,261 | 116.00K |
| 446 | XLO | Xilio Therapeutics, Inc. | 39.50M | -0.09% | 198,639 | 31.80M |
| 447 | RNTX | Rein Therapeutics Inc. | 39.43M | 1.35% | 82,311 | - |
| 448 | INMB | INmune Bio, Inc. | 39.35M | -1.99% | 345,761 | 50.00K |
| 449 | RADX | Radiopharm Theranostics Limited | 37.71M | 0.46% | 14,998 | 8.20M |
| 450 | LTRN | Lantern Pharma Inc. | 37.69M | 11.59% | 164,797 | - |
| 451 | VERU | Veru Inc. | 37.56M | 5.41% | 151,519 | 16.89M |
| 452 | APLT | Applied Therapeutics, Inc. | 37.27M | -0.15% | 5,751,109 | 1.00M |
| 453 | OKUR | OnKure Therapeutics, Inc. | 37.26M | 6.59% | 453,813 | - |
| 454 | TVRD | Tvardi Therapeutics, Inc. | 36.77M | - | 132,004 | - |
| 455 | MAIA | MAIA Biotechnology, Inc. | 36.62M | 8.50% | 193,525 | - |
| 456 | APLM | Apollomics, Inc. | 36.46M | 17.50% | 30,030 | 198.00K |
| 457 | MURA | Mural Oncology plc | 36.21M | - | 131,221 | - |
| 458 | KLTO | Klotho Neurosciences, Inc. | 36.05M | 7.34% | 810,274 | - |
| 459 | GBIO | Generation Bio Co. | 34.90M | 3.39% | 58,261 | 15.27M |
| 460 | FGEN | FibroGen, Inc. | 34.83M | 2.26% | 21,257 | 8.30M |
| 461 | DYAI | Dyadic International, Inc. | 34.43M | 3.41% | 220,784 | 3.34M |
| 462 | PLUR | Pluri Inc. | 33.50M | -4.74% | 30,776 | 1.33M |
| 463 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 33.11M | 6.59% | 584,214 | 1.00M |
| 464 | ANTX | AN2 Therapeutics, Inc. | 29.87M | - | 22,925 | - |
| 465 | LNAI | Lunai Bioworks Inc. | 29.76M | 2.42% | 188,022 | - |
| 466 | IGC | IGC Pharma, Inc. | 29.62M | 1.27% | 363,331 | 1.11M |
| 467 | HYPD | Hyperion DeFi, Inc. | 29.30M | 2.00% | 341,096 | 345.32K |
| 468 | BRNS | Barinthus Biotherapeutics plc | 29.01M | -1.92% | 85,272 | 14.97M |
| 469 | RNXT | RenovoRx, Inc. | 28.79M | -1.27% | 250,210 | 928.00K |
| 470 | CLGN | CollPlant Biotechnologies Ltd. | 28.23M | - | 18,737 | 2.40M |
| 471 | NRXS | NeurAxis, Inc. | 27.48M | -1.53% | 50,447 | 3.36M |
| 472 | PASG | Passage Bio, Inc. | 27.21M | 10.59% | 29,574 | - |
| 473 | RLYB | Rallybio Corporation | 26.85M | 1.34% | 534,495 | 674.00K |
| 474 | NRSN | NeuroSense Therapeutics Ltd. | 26.55M | -3.64% | 1,249,102 | - |
| 475 | NERV | Minerva Neurosciences, Inc. | 26.44M | -4.06% | 59,373 | - |
| 476 | XCUR | Exicure, Inc. | 26.26M | -1.20% | 33,301 | 500.00K |
| 477 | LIXT | Lixte Biotechnology Holdings, Inc. | 25.67M | 4.41% | 101,055 | - |
| 478 | QTTB | Q32 Bio Inc. | 25.59M | 4.00% | 17,971 | - |
| 479 | DARE | Daré Bioscience, Inc. | 25.58M | 6.55% | 49,173 | -57.13K |
| 480 | INTS | Intensity Therapeutics, Inc. | 25.30M | 3.16% | 1,664,785 | - |
| 481 | IBIO | iBio, Inc. | 24.96M | 5.71% | 799,438 | 500.00K |
| 482 | BOLD | Boundless Bio, Inc. | 24.85M | -1.77% | 110,643 | - |
| 483 | ENLV | Enlivex Therapeutics Ltd. | 24.78M | 13.74% | 208,562,214 | - |
| 484 | CASI | CASI Pharmaceuticals, Inc. | 24.56M | -2.85% | 25,888 | 26.85M |
| 485 | QNTM | Quantum BioPharma Ltd. | 24.34M | 7.64% | 59,419 | - |
| 486 | CING | Cingulate Inc. | 23.85M | - | 70,664 | - |
| 487 | NEUP | Neuphoria Therapeutics Inc. | 23.82M | -0.67% | 61,865 | 15.65M |
| 488 | LEXX | Lexaria Bioscience Corp. | 23.58M | 0.95% | 47,161 | 615.92K |
| 489 | LIMN | Liminatus Pharma, Inc. | 22.81M | 17.25% | 898,297 | - |
| 490 | PTN | Palatin Technologies, Inc. | 22.39M | -12.36% | 251,581 | 8.85M |
| 491 | NNVC | NanoViricides, Inc. | 22.32M | -2.36% | 217,312 | - |
| 492 | ITRM | Iterum Therapeutics plc | 22.17M | 8.75% | 969,879 | 390.00K |
| 493 | GDTC | CytoMed Therapeutics Limited | 21.93M | 1.06% | 8,941 | 573.19K |
| 494 | GLTO | Galecto, Inc. | 21.65M | -2.74% | 210,346 | - |
| 495 | CTXR | Citius Pharmaceuticals, Inc. | 21.06M | - | 1,108,194 | - |
| 496 | CVKD | Cadrenal Therapeutics, Inc. | 20.84M | -1.47% | 18,101 | - |
| 497 | APVO | Aptevo Therapeutics Inc. | 19.88M | 4.42% | 423,386 | - |
| 498 | TRAW | Traws Pharma, Inc. | 19.42M | 5.19% | 526,675 | 2.85M |
| 499 | SYBX | Synlogic, Inc. | 19.19M | 1.24% | 4,864 | 8.00K |
| 500 | MRKR | Marker Therapeutics, Inc. | 18.84M | 6.60% | 351,136 | 4.69M |
| 501 | ABP | Abpro Holdings, Inc. | 18.77M | -1.85% | 46,991 | 183.00K |
| 502 | MBRX | Moleculin Biotech, Inc. | 18.64M | -14.30% | 7,068,160 | - |
| 503 | TPST | Tempest Therapeutics, Inc. | 18.52M | 19.14% | 637,059 | - |
| 504 | MTVA | MetaVia Inc. | 18.14M | 7.88% | 169,715 | - |
| 505 | LPCN | Lipocine Inc. | 18.04M | 2.85% | 13,306 | 4.32M |
| 506 | HOTH | Hoth Therapeutics, Inc. | 17.69M | 5.07% | 215,362 | - |
| 507 | PMN | ProMIS Neurosciences, Inc. | 17.55M | -22.36% | 4,003,857 | - |
| 508 | ATHA | Athira Pharma, Inc. | 17.41M | -4.13% | 17,195 | - |
| 509 | LSTA | Lisata Therapeutics, Inc. | 17.29M | - | 26,433 | 1.07M |
| 510 | ALLR | Allarity Therapeutics, Inc. | 16.99M | 10.38% | 79,865 | - |
| 511 | OSRH | OSR Holdings, Inc. | 16.68M | 15.48% | 29,368,405 | -90.52K |
| 512 | QNRX | Quoin Pharmaceuticals, Ltd. | 16.44M | 7.05% | 51,409 | - |
| 513 | PULM | Pulmatrix, Inc. | 16.22M | -5.53% | 6,718 | 3.00K |
| 514 | BCTX | BriaCell Therapeutics Corp. | 15.97M | 6.25% | 71,682 | - |
| 515 | NCNA | NuCana plc | 15.82M | 8.57% | 70,451 | - |
| 516 | AKTX | Akari Therapeutics, Plc | 15.80M | -1.76% | 164,051 | - |
| 517 | CANF | Can-Fite BioPharma Ltd. | 15.62M | 11.99% | 3,407,186 | 560.00K |
| 518 | KZIA | Kazia Therapeutics Limited | 15.50M | 1.20% | 120,106 | 1.20M |
| 519 | NCEL | NewcelX Ltd. | 15.27M | 2.45% | 18,593 | - |
| 520 | KAPA | Kairos Pharma, Ltd. | 15.16M | 8.25% | 174,522 | - |
| 521 | PCSA | Processa Pharmaceuticals, Inc. | 14.87M | 3.79% | 663,039 | - |
| 522 | CRIS | Curis, Inc. | 14.74M | -2.56% | 57,940 | 11.65M |
| 523 | BCDA | BioCardia, Inc. | 14.65M | 0.73% | 32,168 | 3.00K |
| 524 | SNGX | Soligenix, Inc. | 14.42M | 1.42% | 446,300 | 2.34K |
| 525 | BLRX | BioLineRx Ltd. | 14.41M | 4.62% | 52,431 | 12.74M |
| 526 | DWTX | Dogwood Therapeutics, Inc. | 14.24M | -2.05% | 9,576 | - |
| 527 | AIXC | AIxCrypto Holdings, Inc. | 13.52M | 3.15% | 97,546 | - |
| 528 | FBLG | FibroBiologics, Inc. | 13.38M | -23.53% | 4,420,599 | - |
| 529 | LGVN | Longeveron Inc. | 13.34M | 4.18% | 370,646 | 1.44M |
| 530 | COCP | Cocrystal Pharma, Inc. | 13.22M | 6.41% | 62,880 | - |
| 531 | PHIO | Phio Pharmaceuticals Corp. | 12.49M | 3.57% | 511,940 | - |
| 532 | CMMB | Chemomab Therapeutics Ltd. | 12.47M | -4.74% | 73,777 | - |
| 533 | CLRB | Cellectar Biosciences, Inc. | 12.30M | 1.40% | 26,767 | - |
| 534 | EDSA | Edesa Biotech, Inc. | 12.21M | 2.38% | 21,170 | - |
| 535 | VYNE | VYNE Therapeutics Inc. | 12.15M | 3.69% | 679,731 | 524.00K |
| 536 | IMRN | Immuron Limited | 11.84M | -0.60% | 51,234 | 4.78M |
| 537 | IMNN | Imunon, Inc. | 11.51M | 3.02% | 14,414 | - |
| 538 | SNSE | Sensei Biotherapeutics, Inc. | 11.32M | 2.97% | 25,011 | - |
| 539 | GOVX | GeoVax Labs, Inc. | 11.29M | -3.06% | 619,476 | 3.35M |
| 540 | ICU | SeaStar Medical Holding Corporation | 11.00M | 0.07% | 694,412 | 881.00K |
| 541 | PPCB | Propanc Biopharma, Inc. | 10.82M | -0.07% | 12,991 | - |
| 542 | ASBP | Aspire Biopharma Holdings, Inc. | 10.75M | 2.67% | 17,027,295 | 1.94K |
| 543 | APM | Aptorum Group Limited | 10.67M | 0.77% | 62,649 | - |
| 544 | BIVI | BioVie Inc. | 10.18M | 4.25% | 56,438 | - |
| 545 | ERNA | Ernexa Therapeutics Inc. | 10.13M | -4.44% | 35,528 | 1,000.00 |
| 546 | CELZ | Creative Medical Technology Holdings, Inc. | 10.05M | -0.37% | 62,854 | 6.00K |
| 547 | EVGN | Evogene Ltd. | 9.84M | 1.77% | 40,814 | 8.02M |
| 548 | CLDI | Calidi Biotherapeutics, Inc. | 9.81M | -2.19% | 57,459 | - |
| 549 | ENTO | Entero Therapeutics, Inc. | 9.72M | 10.31% | 38,092 | - |
| 550 | AEON | AEON Biopharma, Inc. | 9.60M | -0.61% | 134,896 | - |
| 551 | BOLT | Bolt Biotherapeutics, Inc. | 9.58M | 5.27% | 35,172 | 5.20M |
| 552 | BRTX | BioRestorative Therapies, Inc. | 9.32M | -4.37% | 55,126 | 383.40K |
| 553 | INAB | IN8bio, Inc. | 9.08M | 15.29% | 174,016 | - |
| 554 | ACXP | Acurx Pharmaceuticals, Inc. | 8.63M | -4.83% | 37,925 | - |
| 555 | MBIO | Mustang Bio, Inc. | 8.61M | - | 118,692 | - |
| 556 | PHGE | BiomX Inc. | 8.37M | 13.22% | 1,109,960 | - |
| 557 | RNAZ | TransCode Therapeutics, Inc. | 8.30M | 4.75% | 6,025 | - |
| 558 | GTBP | GT Biopharma, Inc. | 8.10M | 3.69% | 713,271 | - |
| 559 | PLRZ | Polyrizon Ltd. | 8.05M | 6.94% | 72,690 | - |
| 560 | ALZN | Alzamend Neuro, Inc. | 7.91M | 6.12% | 96,390 | - |
| 561 | XTLB | XTL Biopharmaceuticals Ltd. | 7.84M | 8.29% | 34,822 | 451.00K |
| 562 | TOVX | Theriva Biologics, Inc. | 7.79M | 6.90% | 2,394,376 | - |
| 563 | ADIL | Adial Pharmaceuticals, Inc. | 7.77M | 7.61% | 376,564 | - |
| 564 | TCRT | Alaunos Therapeutics, Inc. | 7.50M | 6.33% | 64,579 | 6.00K |
| 565 | APRE | Aprea Therapeutics, Inc. | 7.38M | - | 22,338 | 488.24K |
| 566 | ADXN | Addex Therapeutics Ltd | 7.29M | -7.12% | 6,256 | 210.35K |
| 567 | BGMS | Bio Green Med Solution, Inc. | 6.91M | 12.80% | 32,383 | 81.00K |
| 568 | GRI | GRI Bio, Inc. | 6.83M | 1.95% | 259,542 | - |
| 569 | KPRX | Kiora Pharmaceuticals, Inc. | 6.68M | -2.67% | 21,920 | 20.00K |
| 570 | PPBT | Purple Biotech Ltd | 6.10M | 7.38% | 752,900 | - |
| 571 | ENSC | Ensysce Biosciences, Inc. | 5.91M | 5.03% | 56,894 | 4.49M |
| 572 | VIVS | VivoSim Labs, Inc. | 5.87M | 3.69% | 43,393 | 140.00K |
| 573 | HCWB | HCW Biologics Inc. | 5.86M | - | 34,878 | 422.03K |
| 574 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.81M | 23.21% | 57,041 | 15.78K |
| 575 | SILO | Silo Pharma, Inc. | 5.67M | 9.17% | 220,274 | 72.10K |
| 576 | CYCN | Cyclerion Therapeutics, Inc. | 5.67M | 0.68% | 43,363 | 2.86M |
| 577 | XBIO | Xenetic Biosciences, Inc. | 5.64M | 1.65% | 54,911 | 2.86M |
| 578 | SLRX | Salarius Pharmaceuticals, Inc. | 5.54M | 8.64% | 702,420 | - |
| 579 | LYRA | Lyra Therapeutics, Inc. | 5.41M | -5.28% | 110,676 | 600.00K |
| 580 | KALA | KALA BIO, Inc. | 5.07M | -0.48% | 99,282 | - |
| 581 | MTNB | Matinas BioPharma Holdings, Inc. | 5.06M | -4.24% | 55,943 | - |
| 582 | REVB | Revelation Biosciences, Inc. | 5.04M | -0.44% | 88,759 | - |
| 583 | JAGX | Jaguar Health, Inc. | 4.74M | 4.96% | 405,491 | 11.79M |
| 584 | CLSD | Clearside Biomedical, Inc. | 4.71M | -66.92% | 5,142,968 | 3.33M |
| 585 | GLMD | Galmed Pharmaceuticals Ltd. | 4.65M | 1.43% | 152,066 | - |
| 586 | GNPX | Genprex, Inc. | 4.57M | -6.67% | 169,729 | - |
| 587 | PMCB | PharmaCyte Biotech, Inc. | 4.42M | -1.52% | 30,167 | - |
| 588 | PTIX | Protagenic Therapeutics, Inc. | 4.35M | 9.66% | 113,575 | - |
| 589 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 4.27M | - | 62,739 | 1.36M |
| 590 | CNSP | CNS Pharmaceuticals, Inc. | 4.24M | -0.87% | 8,560 | - |
| 591 | XRTX | XORTX Therapeutics Inc. | 4.24M | 8.14% | 110,978 | - |
| 592 | SPRC | SciSparc Ltd. | 4.02M | 2.90% | 29,359 | 1.31M |
| 593 | OGEN | Oragenics, Inc. | 3.94M | 5.54% | 50,724 | - |
| 594 | ONCO | Onconetix, Inc. | 3.67M | 6.33% | 12,255 | 1.22M |
| 595 | ARTL | Artelo Biosciences, Inc. | 3.59M | 6.59% | 15,310 | - |
| 596 | ELAB | PMGC Holdings Inc. | 3.58M | 1.91% | 28,661 | -241.53K |
| 597 | ENVB | Enveric Biosciences, Inc. | 3.44M | -3.52% | 27,403 | - |
| 598 | INDP | Indaptus Therapeutics, Inc. | 3.34M | 3.24% | 35,132 | - |
| 599 | AZTR | Azitra, Inc. | 3.30M | 2.93% | 310,640 | 7.50K |
| 600 | KTTA | Pasithea Therapeutics Corp. | 3.16M | 45.33% | 68,404,721 | - |
| 601 | DRMA | Dermata Therapeutics, Inc. | 3.04M | 13.85% | 111,914 | - |
| 602 | SCNI | Scinai Immunotherapeutics Ltd. | 2.85M | 2.83% | 18,161 | 1.15M |
| 603 | CDT | CDT Equity Inc. | 2.85M | 6.06% | 25,081 | - |
| 604 | PBM | Psyence Biomedical Ltd. | 2.83M | 1.34% | 313,187 | - |
| 605 | BDRX | Biodexa Pharmaceuticals Plc | 2.68M | -1.37% | 160,667 | 104.90K |
| 606 | ADTX | Aditxt, Inc. | 2.00M | 27.96% | 1,233,776 | 5.95K |
| 607 | MLEC | Moolec Science SA | 1.78M | -1.56% | 367,330 | 7.83M |
| 608 | VRAX | Virax Biolabs Group Limited | 1.65M | 1.76% | 82,666 | 6.33K |
| 609 | SLXN | Silexion Therapeutics Corp | 1.25M | 0.90% | 78,978 | - |
| 610 | CMND | Clearmind Medicine Inc. | 1.09M | 8.41% | 5,646,795 | - |